Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Thorax. 2012 Oct;67(10):882–890. doi: 10.1136/thoraxjnl-2012-202550

Table 1.

CF therapeutics evaluated by the TDN and approved by the FDA

Medication Therapeutic area FDA
approval
Pancrelipase Pancreatic enzyme replacement
therapy
 (Creon, Zenpep) 2009
 (Pancreaze) 2010
 (Pertzye) 2012
Aztreonam lysate for inhalation
(Cayston)
Inhaled antibiotic 2010
Ivacaftor (Kalydeco) CFTR potentiator 2012

CF, cystic fibrosis; TDN, Therapeutics Development Network.